Sulaquin, Gina F.
HRN: 21-53-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/16/2022
07/22/2022
IVT
100mg
Q6 X 7 Days
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes